Implication of different effector mechanisms by cord blood-derived and peripheral blood-derived cytokine-induced killer cells to kill precursor B acute lymphoblastic leukemia cell lines.
about
Revving up Natural Killer Cells and Cytokine-Induced Killer Cells Against Hematological Malignancies.Efficacy and safety of cord blood-derived dendritic cells plus cytokine-induced killer cells combined with chemotherapy in the treatment of patients with advanced gastric cancer: a randomized Phase II study.The cytotoxic action of the CD56+ fraction of cytokine-induced killer cells against a K562 cell line is mainly restricted to the natural killer cell subset.Anticancer cellular immunotherapies derived from umbilical cord blood.Cytokine-induced killer cells as a feasible adoptive immunotherapy for the treatment of lung cancer.
P2860
Implication of different effector mechanisms by cord blood-derived and peripheral blood-derived cytokine-induced killer cells to kill precursor B acute lymphoblastic leukemia cell lines.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Implication of different effec ...... hoblastic leukemia cell lines.
@en
Implication of different effec ...... hoblastic leukemia cell lines.
@nl
type
label
Implication of different effec ...... hoblastic leukemia cell lines.
@en
Implication of different effec ...... hoblastic leukemia cell lines.
@nl
prefLabel
Implication of different effec ...... hoblastic leukemia cell lines.
@en
Implication of different effec ...... hoblastic leukemia cell lines.
@nl
P2093
P1433
P1476
Implication of different effec ...... hoblastic leukemia cell lines.
@en
P2093
François Fontaine
Ludovic Durrieu
Mame Massar Dieng
Michel Duval
William Lemieux
P304
P356
10.1016/J.JCYT.2013.12.010
P577
2014-02-12T00:00:00Z